Morgan Stanley has recently filed a free writing prospectus, indicating its ongoing efforts to engage with investors and secure capital. This filing is particularly important as it relates to the preliminary pricing supplement number 19,658. The document showcases the company's proactive approach in a competitive financial landscape.
Background
Morgan Stanley, a prominent player in the financial services sector, operates under the SIC code 6211, which encompasses Security Brokers, Dealers & Flotation Companies. The company is listed on the New York Stock Exchange under the ticker symbol MS and is categorized as a large accelerated filer. Recent filings include multiple preliminary pricing supplements, all dated October 26, 2026.
What the Filing Says
The filing, dated October 26, 2026, includes a free writing prospectus related to the preliminary pricing supplement. It states, "FREE WRITING PROSPECTUS TO PRELIMINARY PRICING SUPPLEMENT NO. 19,658." This indicates the company's ongoing capital-raising activities.
Impact
This filing may affect investors looking for opportunities in the securities market, as well as competitors in the security brokerage industry. The ongoing capital activities signal Morgan Stanley's commitment to maintaining its market position and responding to investor needs.
What's Next
The filing does not say what happens next.
Filing Details
The filing was accepted on October 26, 2026, at 13:26:32, and includes two documents: a free writing prospectus and a graphic. The free writing prospectus is specifically linked to preliminary pricing supplement number 19,658, which suggests a structured approach to capital raising.
Company Information
Morgan Stanley is incorporated in Delaware and has a fiscal year ending on December 31. The company operates under the Standard Industrial Code (SIC) 6211, which pertains to Security Brokers, Dealers & Flotation Companies. Its Central Index Key (CIK) is 0000895421, and its Employer Identification Number (EIN) is 363145972.
Contact Information
The business address for Morgan Stanley is 1585 Broadway, New York, NY 10036, with a contact number of 212-761-4000. This information may be useful for investors looking to reach out for further inquiries regarding the filing or investment opportunities.
Document Access
Investors and interested parties can access the filing documents directly through the SEC's EDGAR database. The free writing prospectus and the associated graphic can be found at the following links: Free Writing Prospectus and Graphic Document.
